Heart attack breakthrough? common drug may shield your heart from future failure
NCT ID NCT05764057
Summary
This study is testing if dapagliflozin, a medication originally for diabetes, can help prevent heart failure in people who have just had a serious heart attack and have weakened heart function. About 450 participants will take either the drug or a placebo pill daily for six months, on top of their standard heart medications. The main goal is to see if the drug helps the heart pump better and prevents harmful changes in heart shape, which are key predictors of future heart problems and death.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEFT VENTRICULAR DYSFUNCTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Cardiology AP-HP Hôpital européen Georges - Pompidou
RECRUITINGParis, 75015, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.